Role of 18F-Choline PET/CT in restaging patients with prostate cancer with trigger PSA < 1 ng/ml

被引:0
|
作者
Marzola, M. C. [1 ]
Chondrogiannis, S. [1 ]
Ferretti, A. [2 ]
Maffione, A. M. [1 ]
Rampin, L. [1 ]
Massaro, A. [1 ]
Grassetto, G. [1 ]
Rubello, D. [1 ]
机构
[1] Santa Maria della Misericordia Hosp, Nucl Med PET CT Ctr, Rovigo, Italy
[2] Santa Maria della Misericordia Hosp, Med Phys & Biostat Unit, Rovigo, Italy
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S286 / S286
页数:1
相关论文
共 50 条
  • [31] Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
    Jan D. Soyka
    Marco A. Muster
    Daniel T. Schmid
    Burkhardt Seifert
    Ulrike Schick
    Raymond Miralbell
    Sandra Jorcano
    Kathrin Zaugg
    Hans-Helge Seifert
    Patrick Veit-Haibach
    Klaus Strobel
    Niklaus G. Schaefer
    Daniela B. Husarik
    Thomas F. Hany
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 936 - 943
  • [32] 11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml
    Giampiero Giovacchini
    Priscilla Guglielmo
    Paola Mapelli
    Elena Incerti
    Ana Maria Samanes Gajate
    Elisabetta Giovannini
    Mattia Riondato
    Alberto Briganti
    Luigi Gianolli
    Andrea Ciarmiello
    Maria Picchio
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 921 - 929
  • [33] Appropriateness of prescription of 18F-Choline PET/CT in 218 patients with prostate cancer
    Chondrogiannis, S.
    Marzola, M. C.
    Grassetto, G.
    Borotto, G.
    Tommasi, E.
    Tamiso, L.
    Maffione, A. M.
    Pavan, L.
    Rampin, L.
    Rubello, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S719 - S719
  • [34] Optimizing the acquisition protocol of 18F-Choline PET/CT in prostate cancer patients
    Massaro, Arianna
    Cittadin, Silvia
    Milan, Elisa
    Tamiso, Luca
    Lara, Pavan
    Enrico, Tommasi
    Marzola, Maria Cristina
    Grassetto, Gaia
    Rubello, Domenico
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [35] Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
    Soyka, Jan D.
    Muster, Marco A.
    Schmid, Daniel T.
    Seifert, Burkhardt
    Schick, Ulrike
    Miralbell, Raymond
    Jorcano, Sandra
    Zaugg, Kathrin
    Seifert, Hans-Helge
    Veit-Haibach, Patrick
    Strobel, Klaus
    Schaefer, Niklaus G.
    Husarik, Daniela B.
    Hany, Thomas F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (06) : 936 - 943
  • [36] EARLY AND LATE IMAGES OF 18F-CHOLINE (FCH) PET/CT FOR THE DETECTION OF PROSTATIC FOSSAE RECURRENCES IN PROSTATE CANCER WITH A BIOCHEMICAL FAILURE (PSA &gt; 2 NG/ML)
    Zattoni, Fabio
    Cattaneo, Francesco
    Zattoni, Filiberto
    Evangelista, Laura
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1030 - E1031
  • [37] PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?
    Agostino Chiaravalloti
    Daniele Di Biagio
    Mario Tavolozza
    Ferdinando Calabria
    Orazio Schillaci
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1418 - 1424
  • [38] IS [11C]CHOLINE PET/CT RECOMMENDED FOR RESTAGING PROSTATE CANCER PATIENTS AFTER RADICAL PROSTATECTOMY WHEN PSA IS LOWER THAN 1 NG/ML?
    Tutolo, Manuela
    Briganti, Alberto
    Suardi, Nazareno
    Gallina, Andrea
    Abdollah, Firas
    Parra, Rita Garcia
    Picchio, Maria
    Giovacchini, Giampiero
    Gianolli, Luigi
    Messa, Maria Cristina
    Di Trapani, Ettore
    Zanni, Giuseppe
    Passoni, Niccolo Maria
    Fossati, Nicola
    Guazzoni, Giorgio
    Rigatti, Patrizio
    Montorsi, Francesco
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E78 - E79
  • [39] Is [11C]choline PET/CT recommended for restaging prostate cancer patients after radical prostatectomy when PSA is lower than 1 ng/ml?
    Parra, Garcia R.
    Picchio, M.
    Giovacchini, G.
    Briganti, A.
    Gianolli, L.
    Messa, C.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E891 - U875
  • [40] Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients:: Meaningful at PSA &lt; 5 ng/ml?
    Heinisch, M
    Dirisamer, A
    Loidl, W
    Stoiber, F
    Gruy, B
    Haim, S
    Langsteger, W
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2006, 8 (01) : 43 - 48